Acadia Healthcare (NASDAQ:ACHC) Downgraded to Sell at ValuEngine

Acadia Healthcare (NASDAQ:ACHC) was downgraded by ValuEngine from a “hold” rating to a “sell” rating in a research note issued to investors on Tuesday, ValuEngine reports.

A number of other equities analysts have also recently weighed in on the stock. Raymond James cut shares of Acadia Healthcare from a “strong-buy” rating to an “outperform” rating and set a $45.00 price objective for the company. in a research report on Wednesday, July 31st. BidaskClub raised shares of Acadia Healthcare from a “sell” rating to a “hold” rating in a research report on Wednesday, November 6th. Zacks Investment Research cut shares of Acadia Healthcare from a “hold” rating to a “sell” rating and set a $31.00 price objective for the company. in a research report on Wednesday, August 7th. Jefferies Financial Group set a $40.00 price objective on shares of Acadia Healthcare and gave the stock a “buy” rating in a research report on Thursday, October 10th. Finally, UBS Group increased their price objective on shares of Acadia Healthcare from $29.00 to $34.00 and gave the stock a “neutral” rating in a research report on Friday, September 20th. Two equities research analysts have rated the stock with a sell rating, six have issued a hold rating and three have given a buy rating to the company. The company presently has a consensus rating of “Hold” and an average target price of $36.00.

NASDAQ:ACHC opened at $31.77 on Tuesday. The company has a debt-to-equity ratio of 1.49, a quick ratio of 1.17 and a current ratio of 1.17. The stock has a market capitalization of $2.74 billion, a P/E ratio of 14.18, a PEG ratio of 1.46 and a beta of 0.66. The company has a 50 day moving average price of $30.45 and a 200 day moving average price of $31.29. Acadia Healthcare has a fifty-two week low of $24.27 and a fifty-two week high of $35.40.

Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings data on Tuesday, November 5th. The company reported $0.52 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.55 by ($0.03). The company had revenue of $777.25 million for the quarter, compared to analysts’ expectations of $790.39 million. Acadia Healthcare had a positive return on equity of 7.31% and a negative net margin of 6.88%. The business’s revenue for the quarter was up 2.1% on a year-over-year basis. During the same period in the previous year, the business posted $0.55 EPS. Research analysts forecast that Acadia Healthcare will post 2.01 earnings per share for the current fiscal year.

In other Acadia Healthcare news, CEO Debra K. Osteen bought 20,000 shares of Acadia Healthcare stock in a transaction on Thursday, September 5th. The shares were bought at an average cost of $26.53 per share, for a total transaction of $530,600.00. Following the acquisition, the chief executive officer now directly owns 117,178 shares in the company, valued at $3,108,732.34. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 2.60% of the stock is owned by corporate insiders.

A number of institutional investors have recently added to or reduced their stakes in ACHC. BBVA USA Bancshares Inc. raised its holdings in shares of Acadia Healthcare by 53.8% in the 3rd quarter. BBVA USA Bancshares Inc. now owns 19,300 shares of the company’s stock valued at $599,000 after purchasing an additional 6,750 shares in the last quarter. GW&K Investment Management LLC raised its holdings in shares of Acadia Healthcare by 17.0% in the 3rd quarter. GW&K Investment Management LLC now owns 739,793 shares of the company’s stock valued at $22,992,000 after purchasing an additional 107,577 shares in the last quarter. BB&T Corp raised its holdings in shares of Acadia Healthcare by 4.5% in the 3rd quarter. BB&T Corp now owns 60,576 shares of the company’s stock valued at $1,882,000 after purchasing an additional 2,633 shares in the last quarter. Sciencast Management LP acquired a new stake in shares of Acadia Healthcare in the 3rd quarter valued at $278,000. Finally, California Public Employees Retirement System raised its holdings in shares of Acadia Healthcare by 22.6% in the 3rd quarter. California Public Employees Retirement System now owns 161,860 shares of the company’s stock valued at $5,031,000 after purchasing an additional 29,882 shares in the last quarter.

About Acadia Healthcare

Acadia Healthcare Company, Inc develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities in the United States, the United Kingdom, and Puerto Rico.

Featured Story: What is the Bid-Ask Spread?

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.